Cargando…

A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE

For antiviral screenings purposes, infection of cell cultures with the virus under study, should ideally result in the induction, within just a few days, of (nearly) complete CPE and allow the calculation of acceptable Z’ factors (>0.5). The human Corona virus NL63 (HCoV-NL63) causes only limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Jochmans, Dirk, Leyssen, Pieter, Neyts, Johan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112866/
https://www.ncbi.nlm.nih.gov/pubmed/22575574
http://dx.doi.org/10.1016/j.jviromet.2012.04.011
_version_ 1783513560536580096
author Jochmans, Dirk
Leyssen, Pieter
Neyts, Johan
author_facet Jochmans, Dirk
Leyssen, Pieter
Neyts, Johan
author_sort Jochmans, Dirk
collection PubMed
description For antiviral screenings purposes, infection of cell cultures with the virus under study, should ideally result in the induction, within just a few days, of (nearly) complete CPE and allow the calculation of acceptable Z’ factors (>0.5). The human Corona virus NL63 (HCoV-NL63) causes only limited CPE on different cell lines (Schildgen et al., 2006). Following infection of Vero118 cells, virus-induced CPE was too low to allow readout based on classical colorimetric methods (such as the MTS assay), even following prolonged incubation times (>7 days). To develop an antiviral screenings-assay against HCoV-NL63, we explored whether a dead-cell protease substrate could be used instead. The substrate used is a quenched peptide (bis-AAF-R110) that releases a fluorophore upon proteolytic-cleavage by proteases; the latter released from dead cells. Following different rounds of optimization a screening protocol was developed: Vero118 cells in 96-well plate format were infected with HCoV-NL63 (MOI = 0.01; 200 μL cell culture; 2.10(4) cells/mL, IMDM 5% FBS medium). Cultures were subsequently incubated for 5 days at 35 °C after which 20 μL of the peptide solution was added. Fluorescence was quantitated 2 hr after incubation at 37 °C. A roughly 3-fold increase in fluorescence intensity in the infected cultures was observed as compared to the uninfected cultures with a low well-to-well variability. Z’ factors calculated from different experiments were in the range of 0.6–0.8, indicating excellent assay quality. An anti-ACE2 polyclonal antiserum (that prevents coronavirus infection in cell cultures) was used as a positive control and allowed to validate the assay for antiviral screening purposes. In conclusion, in conditions where a viability staining is inadequate to quantitate virus-induced CPE, a novel simple and convenient method that detects cell-death and that is suitable for high-throughput screening purposes can be employed.
format Online
Article
Text
id pubmed-7112866
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-71128662020-04-02 A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE Jochmans, Dirk Leyssen, Pieter Neyts, Johan J Virol Methods Article For antiviral screenings purposes, infection of cell cultures with the virus under study, should ideally result in the induction, within just a few days, of (nearly) complete CPE and allow the calculation of acceptable Z’ factors (>0.5). The human Corona virus NL63 (HCoV-NL63) causes only limited CPE on different cell lines (Schildgen et al., 2006). Following infection of Vero118 cells, virus-induced CPE was too low to allow readout based on classical colorimetric methods (such as the MTS assay), even following prolonged incubation times (>7 days). To develop an antiviral screenings-assay against HCoV-NL63, we explored whether a dead-cell protease substrate could be used instead. The substrate used is a quenched peptide (bis-AAF-R110) that releases a fluorophore upon proteolytic-cleavage by proteases; the latter released from dead cells. Following different rounds of optimization a screening protocol was developed: Vero118 cells in 96-well plate format were infected with HCoV-NL63 (MOI = 0.01; 200 μL cell culture; 2.10(4) cells/mL, IMDM 5% FBS medium). Cultures were subsequently incubated for 5 days at 35 °C after which 20 μL of the peptide solution was added. Fluorescence was quantitated 2 hr after incubation at 37 °C. A roughly 3-fold increase in fluorescence intensity in the infected cultures was observed as compared to the uninfected cultures with a low well-to-well variability. Z’ factors calculated from different experiments were in the range of 0.6–0.8, indicating excellent assay quality. An anti-ACE2 polyclonal antiserum (that prevents coronavirus infection in cell cultures) was used as a positive control and allowed to validate the assay for antiviral screening purposes. In conclusion, in conditions where a viability staining is inadequate to quantitate virus-induced CPE, a novel simple and convenient method that detects cell-death and that is suitable for high-throughput screening purposes can be employed. Elsevier B.V. 2012-08 2012-04-28 /pmc/articles/PMC7112866/ /pubmed/22575574 http://dx.doi.org/10.1016/j.jviromet.2012.04.011 Text en Copyright © 2012 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Jochmans, Dirk
Leyssen, Pieter
Neyts, Johan
A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
title A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
title_full A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
title_fullStr A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
title_full_unstemmed A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
title_short A novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited CPE
title_sort novel method for high-throughput screening to quantify antiviral activity against viruses that induce limited cpe
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7112866/
https://www.ncbi.nlm.nih.gov/pubmed/22575574
http://dx.doi.org/10.1016/j.jviromet.2012.04.011
work_keys_str_mv AT jochmansdirk anovelmethodforhighthroughputscreeningtoquantifyantiviralactivityagainstvirusesthatinducelimitedcpe
AT leyssenpieter anovelmethodforhighthroughputscreeningtoquantifyantiviralactivityagainstvirusesthatinducelimitedcpe
AT neytsjohan anovelmethodforhighthroughputscreeningtoquantifyantiviralactivityagainstvirusesthatinducelimitedcpe
AT jochmansdirk novelmethodforhighthroughputscreeningtoquantifyantiviralactivityagainstvirusesthatinducelimitedcpe
AT leyssenpieter novelmethodforhighthroughputscreeningtoquantifyantiviralactivityagainstvirusesthatinducelimitedcpe
AT neytsjohan novelmethodforhighthroughputscreeningtoquantifyantiviralactivityagainstvirusesthatinducelimitedcpe